Surprisingly, in association with low levels of CCL23, enrichment of the human HCC tissues with type 1 T-helper (Th1) cells revealed significantly shorter (p = 1.3x10-10) median survival of 9.3 months vs. 56.17 months in HCC patients (Figure 2C). Here, CCL23 is linked to hepatocellular carcinoma.